Added to YB: 2019-07-30
Pitch date: 2019-07-30
ATE:CN [bullish]
Antibe Therapeutics Inc.
-89.46%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Antibe Therapeutics Inc., a biotechnology company, engages in developing novel therapeutics and medical devices in the areas of pain, inflammation and regenerative medicine in Canada, Europe, the United States, and internationally.
Market Cap
CAD 15.6M
Pitch Price
CAD 2.80
Price Target
N/A
Dividend
N/A
EV/EBITDA
N/A
P/E
-0.85
EV/Sales
N/A
Sector
Pharmaceuticals
Category
N/A
Show full summary:
ANTIBE THERAPEUTICS INC COM ATE:CN
A summary for this pitch has not been created yet.
Read full article (0 min)